Vaxcyte, Inc.
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in …
Biotechnology
US, San Carlos [HQ]
Lobbying · US Senate · Influence
Lobbying Analysis
Lobbying · US Senate · Influence
Vaxcyte, Inc. has no lobbying expenses in our database.
| FY | Quarter | Lobby Expense [in mil. $] | Filing | Report Time |
|---|---|---|---|---|
| No data |